↓ Skip to main content

Single dose oral etoricoxib for acute postoperative pain in adults

Overview of attention for article published in Cochrane database of systematic reviews, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
17 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Single dose oral etoricoxib for acute postoperative pain in adults
Published in
Cochrane database of systematic reviews, May 2014
DOI 10.1002/14651858.cd004309.pub4
Pubmed ID
Authors

Rachel Clarke, Sheena Derry, R Andrew Moore

Abstract

This is an updated version of the original Cochrane review first published in Issue 2, 2009, and updated in Issue 4, 2012.Etoricoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor licensed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis, and acute pain in some jurisdictions. This class of drugs is believed to be associated with fewer upper gastrointestinal adverse effects than conventional non-steroidal anti-inflammatory drugs (NSAIDs).

Twitter Demographics

The data shown below were collected from the profiles of 17 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Norway 1 <1%
Brazil 1 <1%
Unknown 100 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 21%
Researcher 12 12%
Student > Bachelor 10 10%
Other 10 10%
Student > Postgraduate 8 8%
Other 27 26%
Unknown 14 14%
Readers by discipline Count As %
Medicine and Dentistry 64 62%
Nursing and Health Professions 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Chemistry 3 3%
Arts and Humanities 2 2%
Other 7 7%
Unknown 15 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2019.
All research outputs
#1,378,216
of 14,282,317 outputs
Outputs from Cochrane database of systematic reviews
#3,909
of 10,940 outputs
Outputs of similar age
#20,695
of 189,788 outputs
Outputs of similar age from Cochrane database of systematic reviews
#76
of 209 outputs
Altmetric has tracked 14,282,317 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,940 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,788 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 209 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.